Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
18.36
-0.49 (-2.60%)
At close: Jul 7, 2026, 4:00 PM EDT
18.65
+0.29 (1.58%)
After-hours: Jul 7, 2026, 5:04 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $5.71 billion as of July 7, 2026. Its market cap has increased by 1,371.17% in one year.
Market Cap
5.71B
Enterprise Value
5.45B
1-Year Change
1,371.17%
Ranking
Category
Stock Price
$18.36
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $5.71B, an increase of 207.25%. That is a compound annual growth rate of 25.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 5.71B | 440.99% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 6.33B |
| CG Oncology | 6.21B |
| Xenon Pharmaceuticals | 5.89B |
| Definium Therapeutics | 5.87B |
| CRISPR Therapeutics AG | 5.79B |
| Legend Biotech | 5.79B |
| Belite Bio | 5.77B |
| Veradermics | 5.42B |